Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines

Annals of Allergy, Asthma and Immunology

Volumn 81, Issue 6, 1998, Pages 601-607

  Paolieri, F ^a   Battifora, M ^a   Riccio, A M ^a   Bertolini, C ^a   Cutolo, M ^a   Bloom, M ^b   Ciprandi, G ^a   Canonica, G W ^a   Bagnasco, M ^a,c  

^a UNIVERSITY OF GENOA   (Italy)

^b SANOFI   (France)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FEXOFENADINE; INTERCELLULAR ADHESION MOLECULE 1; TERFENADINE;

ALLERGIC REACTION; ANTIGEN EXPRESSION; ARTICLE; CELL STIMULATION; DRUG EFFICACY; EPITHELIUM CELL; FIBROBLAST; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MEDIATOR RELEASE; PRIORITY JOURNAL; RECEPTOR UPREGULATION;

EID: 0032435662     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)62712-3     Document Type: Article

References (23)

1. Canonica GW, Ciprandi G, Buscaglia S, et al. Adhesion molecules of allergic inflammation: recent insights into their functional roles. Allergy 1994;49: 489-491.
2. Canonica GW, Pronzato C, Fiorino N, et al. Adhesion molecules: a review of their clinical roles in allergic inflammation. Allergy Clin Immunol News 1993;5(3):80-84.
3. Barnes PJ. Future drug therapy for asthma. Clin Exp Allergy 1991; 21(suppl):80-85.
4. Simons REF, Simons KJ. Antihistamines. In: Middleton F Jr, Reed Ce, Ellis EF, et al, eds. Allergy: principles and practice. Fourth Edition. St Louis: Mosby Year Book Inc, 1993:856-878.
5. Kjellman N-IM, Anderson B. Terfenadine reduces skin and conjunctival reactivity in grass pollen allergic children. Clin Allergy 1986;16:441-449.
6. McTavish D, Goa KL, Ferrill M. Terfenadine: an updated review of its pharmacological properties and therapeutic efficacy. Drugs 1990;39: 552-574.
7. Townley RG, Hopp RJ, Bewtra AK, Nabe M. Effect of terfenadine on pulmonary function, histamine release, and bronchial challenges with nebulized water and cold-air hyperventilation. Ann Allergy 1989;63:455-460.
8. Ciprandi G, Pronzato C, Ricca V, et al. Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy. Clin Exp Allergy 1995;25: 871-878.
9. Akagi M, Mio M, Miyoshi K, Tasaka K. Antiallergic effects of terfenadine on immediate-type hypersensitivity reactions. Immunopharmacol Immunotoxicol 1987;9:257-279.
10. Nabe M, Agrawal DK, Sarmiento EU, Townley RG. Inhibitory effect of ter-fenadine on mediator release from human blood basophils and eosinophils. Clin Exp Allergy 1989;19:515-520.
11. Bousquet J, Lebel B, Chanal I, et al. Antiallergic activity of HI receptor antagonists assessed by nasal challenge. J Allergy Clin Immunol 1988;82: 881-887.
12. Naclerio RM, Kagey-Sobotka A, Lichtenstein LM, et al. Terfenadine, an HI anti-histamine, inhibits histamine release in vivo in the human. Am Rev Respir Dis 1990;142:167-171.
13. Calderon E, Lockey RF. A possible role for adhesion molecules in asthma. J Allergy Clin Immunol 1992;90(5): 852-865.
14. Jeffery PK, Wardlaw AJ, Nelson FC, et al. Bronchial biopsies in asthma: an ultrastructural, quantitative study and correlation with hyperreactivity. Am Rev Respir Dis 1989;140:1745-1753.
15. Montefort CK, Holgate ST. The role of adhesion molecules in inflammation. Respir Med 1991;85:91-99.
16. Wegner CD, Gundel RH, Reilly P, et al. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 1990;247:456-459.
17. Ciprandi G, Buscaglia S, Pesce GP, et al. Allergic subjects express intercellular adhesion molecule 1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge. J Allergy Clin Immunol 1993;91:783-792.
18. Ciprandi G, Buscaglia S, Pesce GP, et al. Deflazacort protects late phase but not early phase events induced by allergen specific conjunctival provocation test. Allergy 1993;48:421-430.
19. Ciprandi G, Buscaglia S, Pesce GP, et al. Ocular challenge and hyperesponsiveness to histamine in patients with allergic conjunctivitis. J Allergy Clin Immunol 1993;91(6):1227-1230.
20. Ciprandi G, Buscaglia S, Iudice A, Canonica GW. Protective effect of different doses of terfenadine on the conjunctival provocation test. Allergy 1992;47:309-312.
21. Tinkelman D, Falliers C, Bronsky E, et al. Efficacy and safety of fexofenadine HCL in fall seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97: 435-441.
22. Cheng HC, Ficorilli JV. Time course of the antihistaminic effects of MDL16,455 A and terfenadine on histamine skin wheals in guinea pigs. Data on file, confidential of Hoechst Marion Roussel.
23. Rimmer SJ, Church MK. The pharmacology and mechanisms of action of histamine H1-antagonists. Clin Exp Allergy 1990;20(Suppl):3-17.